MoneyWorks4Me

Innova Captab - Quaterly Results

08 May 2026 Evaluate
The Sales for the quarter ended March 2026 of Rs. 3582.77 millions rose by 47.73% from Rs. 2425.22 millions.Modest increase of 23.57% in the Net Profit was reported from. 171.25 millions to Rs. 211.62  millions.Operating profit surged to 413.19 millions from the corresponding previous quarter of 325.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3582.77 2425.22 47.73 12988.14 9580.61 35.57 12988.14 9580.61 35.57
Other Income 26.80 43.56 -38.48 132.43 167.75 -21.06 132.43 167.75 -21.06
PBIDT 413.19 325.36 26.99 1646.10 1390.74 18.36 1646.10 1390.74 18.36
Interest 39.81 18.69 113.00 154.21 21.68 611.30 154.21 21.68 611.30
PBDT 373.38 306.67 21.75 1491.89 1369.06 8.97 1491.89 1369.06 8.97
Depreciation 94.03 78.12 20.37 373.67 170.15 119.61 373.67 170.15 119.61
PBT 279.35 228.55 22.23 1118.22 1198.91 -6.73 1118.22 1198.91 -6.73
TAX 67.73 57.30 18.20 281.30 304.21 -7.53 281.30 304.21 -7.53
Deferred Tax 58.38 29.89 95.32 103.65 84.21 23.09 103.65 84.21 23.09
PAT 211.62 171.25 23.57 836.92 894.70 -6.46 836.92 894.70 -6.46
Equity 572.25 572.25 0.00 572.25 572.25 0.00 572.25 572.25 0.00
PBIDTM(%) 11.53 13.42 -14.04 12.67 14.52 -12.69 12.67 14.52 -12.69
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..